CGTX - Cognition Therapeutics GAAP EPS of -$0.21 misses by $0.03
2023-05-04 18:13:02 ET
- Cognition Therapeutics press release ( NASDAQ: CGTX ): Q1 GAAP EPS of -$0.21 misses by $0.03 .
- Cash and cash equivalents on March 31, 2023, were approximately $38.8 million compared to $41.6 million on December 31, 2022.
- Shares -5.99% AH.
For further details see:
Cognition Therapeutics GAAP EPS of -$0.21 misses by $0.03